Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Raymond David Eugene Dupuis Insider Profile
4 Followers
Raymond David Eugene Dupuis, Chief Financial Officer at Kane Biotech, holds 1.09M shares in Kane Biotech (Ticker: TSE:KNE). Most recently, Raymond David Eugene Dupuis Bought C$100,000 shares of Kane Biotech on Jan 20, 2025 for an estimated value of 10.00K.
Raymond David Eugene Dupuis Kane Biotech (KNE)Chief Financial Officer
Kane Biotech (KNE)
Chief Financial Officer
Ranked #8,245 out of 100,336 Corporate Insiders
Profitable Transactions
5 out of 7 Profitable Transactions
Average Return
+30.30%
Average return per transaction
Time Frame
Compare to
Insider Holdings
100.00%
A breakdown of Raymond David Eugene Dupuis's holdings
Insider Roles
Chief Financial Officer
Roles that Raymond David Eugene Dupuis holds in companies
Most Profitable Insider Trade
The most profitable trade made by Raymond David Eugene Dupuis
Raymond David Eugene Dupuis's Trading History
List of latest transactions for each holding click on a transaction to see Raymond David Eugene Dupuis's performance on stock
You May Also Like
Raymond David Eugene Dupuis insider profile FAQ
What is the percentage of profitable transactions made by Raymond David Eugene Dupuis?
The percentage of profitable transactions made by Raymond David Eugene Dupuis is 71%.
What is the average return per transaction made by Raymond David Eugene Dupuis?
The average return per transaction made by Raymond David Eugene Dupuis is 30.30%.
What stocks does Raymond David Eugene Dupuis hold?
Raymond David Eugene Dupuis holds: TSE:KNE stocks.
What was Raymond David Eugene Dupuis’s latest transaction?
Raymond David Eugene Dupuis latest transaction was an Informative Buy of C$10.00K.
What was Raymond David Eugene Dupuis's most profitable transaction?
Raymond David Eugene Dupuis’s most profitable transaction was an Informative Buy of TSE:KNE stock on October 23, 2018. The return on the trade was 92.30%.
What is Raymond David Eugene Dupuis's role in Kane Biotech?
Raymond David Eugene Dupuis's role in Kane Biotech is Chief Financial Officer.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.